hrp0082p2-d3-387 | Fat Metabolism & Obesity (2) | ESPE2014
, Szybowska Patrycja
, Wojcik Malgorzata
, Starzyk Jerzy B
Background: Non-alcoholic fatty liver disease (NAFLD) in obese children is a diagnostic challenge. Presently recommended markers of liver steatosis and risk of progression to fibrosis are: ultrasound imaging (US) and liver aminotransferases (ALT and AST). Owing to the poor sensitivity of these tests, there is a need to search for biomarkers which could indicate early stages of NAFLD. The enhanced liver fibrosis test (ELF) based on the combination of serum concentration of hyal...